Zynex Inc
NASDAQ:ZYXI
Operating Margin
Zynex Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Zynex Inc
NASDAQ:ZYXI
|
60.1m USD |
3%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
227.4B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
184.6B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
152.5B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
143B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.5B USD |
19%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
53B EUR |
13%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.7B USD |
14%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.5B USD |
28%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
38.5B USD |
29%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
266.3B CNY |
36%
|
Zynex Inc
Glance View
Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 774 full-time employees. The company went IPO on 2002-11-27. The Company’s devices are intended for pain management to reduce reliance on drugs and medications and provide rehabilitation and through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current (IFC), neuromuscular electrical stimulation (NMES) and transcutaneous electrical nerve stimulation (TENS). The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, and E-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream, Knee Braces and LSO Back Braces, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter. CM-1500 is a Zynex fluid monitoring system.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Zynex Inc's most recent financial statements, the company has Operating Margin of 3.1%.
You don't have any saved screeners yet